Status:

COMPLETED

Drug Interactions and Bioavailability of Cranberry

Lead Sponsor:

Medical University of South Carolina

Collaborating Sponsors:

National Center for Complementary and Integrative Health (NCCIH)

Office of Dietary Supplements (ODS)

Conditions:

Healthy

Drug Interactions

Eligibility:

All Genders

18-50 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to evaluate the potential of cranberry juice to interact with conventional drugs. This study will also determine the the amount of cranberry flavonoids that appear in the ...

Detailed Description

The use of cranberry (CB) juice and powders, both alone and in combination with conventional medicine, has become more common for the treatment of urinary tract infections (UTIs) and and other acute o...

Eligibility Criteria

Inclusion

  • Females must have a negative urine pregnancy test prior to enrollment and must be committed to using barrier methods of birth control throughout the study.

Exclusion

  • Clinically significant diseases or abnormal laboratory values as assessed during the screening medical history, physical exam, and laboratory evaluations.
  • A history (within the past year) or presence of clinically significant cardiovascular, cerebrovascular, renal, hepatic, gastrointestinal, pulmonary, immunological, hematological, endocrine, or neurologic disease. The exclusion criteria also includes 1) positive urine pregnancy test 2) The use of oral contraceptives 3) The lack of use of acceptable barrier methods of birth control unless abstinent
  • Use of any concomitant medication including herbal medications or a history of hypersensitivity to the medications used in the study
  • History of sensitivity to CB juice or products
  • Poor metabolizers of CYP2D6
  • Active smoking or use of caffeine-containing beverages for 2 weeks prior to and during the study
  • Inability to conform with dietary restrictions required for the study
  • Drug or alcohol abuse (more than 3 drinks/day)

Key Trial Info

Start Date :

October 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2007

Estimated Enrollment :

16 Patients enrolled

Trial Details

Trial ID

NCT00200759

Start Date

October 1 2004

End Date

December 1 2007

Last Update

May 25 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University of South Carolina

Charleston, South Carolina, United States, 29425